Organization
Adam Kittai
1 clinical trial
Clinical trial
A Phase II Study Evaluating the Safety and Efficacy of the Combination of Zanubrutinib Plus Lisocabtagene Maraleucel for Richter's SyndromeStatus: Recruiting, Estimated PCD: 2025-12-31
1 clinical trial